enecadin
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2006 (NCT00331721)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Loading structure…
SMILES
Cc1nc(OCCCCCN2CCCCC2)cc(-c2ccc(F)cc2)n1- Mol. weight
- 357.47 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL29404 ↗
Also known as
- enecadin
- enecadin
- enecadin
- enecadin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00331721 | Phase 2 | May 1, 2006 | PAION Deutschland GmbH, University of Heidelberg |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| PAION Deutschland GmbH | For profit | 1 | 1 | 1 | 2006 |
| University of Heidelberg | Academic/Hospital | 1 | 0 | 1 | 2006 |
2 organizations
Page 1 / 1